Author:Ilaria De Giovanni

Cross roads with cars at night

Blogs/Articles, Rare diseases

Orphan drugs: How to avoid costly stock losses in Europe 
out-licensing

Blogs/Articles, Rare diseases

Out-licensing vs partnering: Strategies for accessing Europe 

Thought Leadership, Rare diseases

Market access for orphan drugs in Switzerland: a guide for US Biotechs
Workplace meeting

Blogs/Articles, Rare diseases

An introduction to PASS studies

News

Sciensus hosts a panel at the World Orphan Drug Congress 2024

Thought Leadership, Rare diseases

The impact of real-world data in gaining access to the European orphan drugs market. 
Navigating Expanded Access Programs in Europe

Thought Leadership, Rare diseases

Navigating early access in Europe: a strategic blueprint for biotech leaders